H1N1 Influenza Virus California/04/2009 Recombinant ( H1N1 California )

Catalog # PT_40071

Print

$201.00
DescriptionRecombinant Hemaglutinin external envelope protein, Full-Length glycosylated H1N1 California/04/2009 with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is approximately 72 kDa.SourceBaculovirus Insect
Product Size: 2ug
Quantity

Data sheet

Formulation
The Recombinant H1N1 A/California/04/2009 solution 10mM Sodium phosphate pH-7, 150mM Sodium Chloride, and 0.005% Tween 20.
Purity
Greater than 90.0% under the conditions that would preserve its biological activity and tertiary structure.
Description
Recombinant Hemaglutinin external envelope protein, Full-Length glycosylated H1N1 California/04/2009 with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is approximately 72 kDa.
Protein Background
H1N1 is subtype specie of Influenza A virus. H1N1 Influenza Virus has mutated into various strains such as the Spanish Flu strain, mild human flu strains, endemic pig strains, and various strains found in birds. The Influenza A Virus is a globular particl
Expression host
Baculovirus Insect Cells.
Reagent Appearance
Sterile Filtered colorless solution.
Stability
The Recombinant H1N1 A/California/04/2009 Recombinant should be stored at 4°C. Do NOT Freeze!
References
1.Title:Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection.Publication: The Rockefeller University Press, doi: 10.1084/jem.20101352 © 2011 Wrammert et al. Link:http://jem.rupress.
Contaminants
Western Blotting: 0.5g/ml.
New